Healthy volunteers needed to test drug interactions for cancer drug candidate
Knowledge-focused
Not yet recruiting
This early-stage study looks at how two common drugs—itraconazole (an antifungal) and ticagrelor (a blood thinner)—change the way the body processes AL3818, a potential cancer treatment. Sixteen healthy adults aged 18 to 45 will take AL3818 alone and then with each other drug. Th…
Phase: PHASE1 • Sponsor: Advenchen Laboratories Nanjing Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC